Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea · Delayed Price · Currency is KRW

2,955.00

+110.00 (3.87%)

At close: Oct 1, 2026

Market Cap	171.17B -48.1%
Revenue (ttm)	50.34B -39.5%
Net Income	-32.83B
EPS	-619.82
Shares Out	60.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	118,367
Open	2,845.00
Previous Close	2,845.00
Day's Range	2,755.00 - 2,960.00
52-Week Range	2,070.00 - 7,000.00
Beta	-0.44
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps for offices, houses, apartments, buildings, factories, and parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon P... [Read more]

Industry Pharmaceutical Preparations

Founded 2002

Employees 307

Stock Exchange KOSDAQ

Ticker Symbol 082800

Full Company Profile

Financial Performance

In 2025, Vivozon Pharmaceutical's revenue was 59.34 billion, a decrease of -32.26% compared to the previous year's 87.60 billion. Losses were -32.42 billion, 224.8% more than in 2024.

Financial Statements